Dean Jones Awarded 2022 Albert E. Levy Award

The Albert E. Levy Award for Excellence in Scientific Research was established to recognize the contributions of Emory faculty members to the advancement of scientific knowledge. This award was created by Edith Levy Elsas, a civic and academic activist, while she was a member of the Emory University Board of Visitors in memory of her father, Albert E. Levy. The award is overseen by the University Research Committee (URC).

Each year the University Research Committee accepts nominations from the faculty at large in recognition of two faculty members, one junior and one senior, considered by the nominating faculty to be outstanding in their respective fields of research.

Senior Award: Dean P. Jones, PhD Dean P. Jones, PhD, joined the Emory faculty in 1985 and is currently Professor of Medicine in the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, with joint and secondary appointments in the Departments of Biochemistry, Ophthalmology, Pediatrics, and the Winship Cancer Institute. He is currently Director of the Emory Clinical Biomarkers Laboratory, Director of the Integrated Health Sciences Facility Core in the HERCULES Exposome Research Center, and Co-Director of the Center for Clinical and Molecular Nutrition. Dr. Jones has developed methods for quantitative detection of endogeneous metabolites, microbiome and environmental pollutants in humans.

Dr. Jones has conducted impactful and prolific research throughout his career at Emory. His recent work describes the development and use of a high-resolution metabolomics platform that provides unsurpassed coverage of endogenous metabolites, microbiome, and environmental pollutants. His group’s analytic methods have been used in numerous studies published in high impact journals and have provided a long-lasting contribution to analytical sciences. Through development and application of new computational tools and integrative omics, Dr. Jones has shown for the first time that high resolution metabolomics data can directly link exposures to disease phenotype. Through collaborations with clinical investigators and epidemiologists studying a broad spectrum of human diseases, including lung, cardiovascular, hepatic, renal, intestinal, endocrine, neurologic, eye, infectious disease, and cancer, as well as preterm and early development and aging, his group has extended applications of their analytic methods to address complex gene-environment interactions that underlie most human disease. Overall, Dr. Jones’s work has enabled a new vision for environmental health and medicine and provided a foundation for research at the interplay of environmental exposer and biological effect